Lee S Schwartzberg Selected Research

Lee S Schwartzberg Research Topics

Disease

45	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2005
40	Neoplasms (Cancer) 01/2021 - 01/2004
21	Vomiting 01/2019 - 02/2007
21	Nausea 01/2019 - 02/2007
11	Neutropenia 01/2020 - 07/2005
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2009
8	Colorectal Neoplasms (Colorectal Cancer) 08/2017 - 09/2007
7	Febrile Neutropenia 10/2018 - 02/2005
5	Triple Negative Breast Neoplasms 10/2021 - 01/2018
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2013
5	Disease Progression 01/2020 - 11/2009
4	Diarrhea 12/2017 - 11/2009
4	Fatigue 01/2016 - 11/2009
3	Hypersensitivity (Allergy) 06/2018 - 06/2007
3	Exanthema (Rash) 05/2015 - 01/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2014 - 09/2008
3	Anemia 05/2006 - 01/2004
2	Brain Neoplasms (Brain Tumor) 09/2017 - 01/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 01/2013
2	Constipation 09/2015 - 09/2015
2	Headache (Headaches) 09/2015 - 09/2015
2	Melanoma (Melanoma, Malignant) 06/2015 - 06/2007
2	Carcinoma (Carcinomatosis) 02/2013 - 08/2002
1	Bone Diseases (Bone Disease) 01/2021

Drug/Important Bio-Agent (IBA)

13	Hormones (Hormone)IBA 01/2021 - 01/2010
9	Capecitabine (Xeloda)FDA Link 12/2017 - 08/2009
8	Docetaxel (Taxotere)FDA Link 01/2020 - 02/2005
8	Bevacizumab (Avastin)FDA Link 08/2017 - 09/2007
7	AnthracyclinesIBA 12/2018 - 09/2015
6	pegfilgrastim (Neulasta)FDA Link 01/2020 - 02/2005
6	Estrogen ReceptorsIBA 01/2020 - 01/2017
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 09/2015
6	taxaneIBA 12/2017 - 08/2009
6	Paclitaxel (Taxol)FDA LinkGeneric 09/2017 - 08/2009
6	Panitumumab (Vectibix)FDA Link 08/2017 - 01/2011
5	human ERBB2 proteinIBA 01/2019 - 05/2013
5	Trastuzumab (Herceptin)FDA Link 01/2019 - 06/2014
5	Pharmaceutical PreparationsIBA 12/2018 - 10/2013
5	Gemcitabine FDA Link 09/2017 - 01/2011
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2015
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 07/2014
4	Fulvestrant (Faslodex)FDA Link 01/2020 - 02/2014
4	AntiemeticsIBA 01/2019 - 07/2007
4	Palonosetron (Aloxi)FDA Link 01/2019 - 07/2012
4	Neurokinin-1 Receptor AntagonistsIBA 12/2018 - 11/2011
4	Dexamethasone (Maxidex)FDA LinkGeneric 12/2018 - 09/2015
4	rolapitantIBA 01/2018 - 09/2015
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2017 - 11/2009
4	Carboplatin (JM8)FDA LinkGeneric 07/2017 - 06/2009
4	Cetuximab (Erbitux)FDA Link 06/2016 - 01/2009
3	Epidermal Growth Factor (EGF)IBA 01/2021 - 01/2020
3	eflapegrastimIBA 01/2020 - 01/2018
3	Androgen Receptors (Androgen Receptor)IBA 11/2019 - 01/2017
3	Biosimilar PharmaceuticalsIBA 01/2019 - 01/2018
3	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 10/2018 - 10/2013
3	Filgrastim (Neupogen)FDA Link 10/2018 - 10/2013
3	Sorafenib (BAY 43-9006)FDA Link 12/2017 - 05/2013
3	etirinotecan pegolIBA 09/2017 - 11/2015
3	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 09/2015 - 07/2012
3	Cisplatin (Platino)FDA LinkGeneric 09/2015 - 01/2011
3	ErbB Receptors (EGF Receptor)IBA 05/2015 - 01/2010
3	Leucovorin (Folinic Acid)FDA Link 07/2014 - 08/2002
3	Fluorouracil (Carac)FDA LinkGeneric 07/2014 - 08/2002
3	Rituximab (Mabthera)FDA Link 06/2011 - 09/2008
2	Immune Checkpoint InhibitorsIBA 04/2020 - 08/2016
2	LigandsIBA 11/2019 - 01/2018
2	fosaprepitant FDA Link 06/2018 - 01/2018
2	Polysorbates (PSML)FDA Link 06/2018 - 01/2018
2	enzalutamideIBA 01/2018 - 08/2017
2	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 09/2015
2	Aromatase InhibitorsIBA 01/2018 - 04/2009
2	Estrogens (Estrogen)FDA Link 12/2017 - 08/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2017 - 10/2013
2	eribulin FDA Link 09/2017 - 01/2016
2	PlatinumIBA 08/2017 - 02/2013
2	Granisetron (Kytril)FDA LinkGeneric 08/2016 - 06/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 09/2015
2	AlbuminsIBA 01/2016 - 02/2013
2	VaccinesIBA 06/2015 - 06/2007
2	Lapatinib (GW572016)FDA Link 05/2015 - 01/2010
2	Taxoids (Taxanes)IBA 05/2015 - 08/2009
2	motesanib diphosphateIBA 05/2015 - 01/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2014 - 09/2007
2	Pemetrexed (MTA)FDA Link 11/2013 - 10/2013
2	Albumin-Bound Paclitaxel FDA Link 02/2013 - 04/2012
2	Hemoglobins (Hemoglobin)IBA 05/2006 - 07/2005
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	olaparibIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2020
1	OF 4647IBA 11/2020

Therapy/Procedure

45	Drug Therapy (Chemotherapy) 01/2021 - 01/2004
29	Therapeutics 10/2021 - 08/2002
6	Radiotherapy 01/2017 - 06/2009
4	Immunotherapy 11/2020 - 06/2007
4	Drug Tapering 07/2014 - 11/2009
3	Neoadjuvant Therapy 10/2021 - 01/2021
3	Biological Therapy 03/2016 - 04/2014
2	Aftercare (After-Treatment) 09/2015 - 01/2013
2	Treatment Delay 10/2013 - 11/2009